EU is struggling to agree a common approach, seen as vital to boost public confidence
Italy, Spain and Belgium have joined other European countries in restricting or recommending the use of the Oxford/AstraZeneca vaccine in older age groups as the EU struggles to agree common guidelines to counter expected public hesitancy.
The European Medicines Agency (EMA) on Wednesday found a possible link between the vaccine and very rare cases of blood clots, although it said its benefits far outweighed its risks and did not announce any restrictions.
